A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. / Roccatello, D; Sciascia, S; Baldovino, S; Rossi, D. - In: ARTHRITIS AND RHEUMATISM. - ISSN 0004-3591. - (2012), pp. S662-S662. ((Intervento presentato al convegno Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP) tenutosi a Washington, DC nel NOV 09-14, 2012.

A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy.

ROCCATELLO, Dario;SCIASCIA, Savino;BALDOVINO, Simone;
2012

Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP)
Washington, DC
NOV 09-14, 2012
S662
S662
Roccatello, D; Sciascia, S; Baldovino, S; Rossi, D
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1594756
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact